|Opti-DHA Enteric-Coated, Douglas Labs|
(Item #: 98531-60X, MSRP: $27.30, Content: 60 SoftGels)
|Free Shipping on 2 or more of this item.|
|Novel ratio of DHA to EPA (Omega-3 fish oil)|
Enteric-Coated Softgels for Cardiovascular Health
Opti-DHA enteric-coated softgels, provided by
Douglas Laboratories, contain a novel ratio of
essential omega-3 fatty acids, derived from marine
lipid concentrate. Processed by molecular distillation,
Opti-DHA is an excellent source of these fatty acids,
providing 450 mg of docosahexeanoic acid(DHA)
and 150 mg eicosapentaenoic acid(EPA) per serving.
The omega-3 fatty acid EPA is the direct precursor
for the anti-inflammatory prostaglandins E1 and E3,
whereas DHA is of primary importance for the
structural integrity of neuronal membranes. DHA is
essential for brain and visual development and is vital
throughout pregnancy to support fetal brain growth
and formation of the retina and visual cortex.
most abundant fatty acid in the brain, adequate
amounts of DHA are needed throughout infancy and
adulthood for ongoing optimal function. Low levels
of DHA may adversely influence behavior and
mental performance, and have been correlated with
changes in disposition, memory loss, and visual and
other neurological conditions.
Studies have shown that DHA, along with EPA may
play an important role in cardiovascular health. One
landmark study, the GISSI-Prevenzione Trial,
involved over 11,000 people who had already
survived myocardial infarction.
This was the first
large scale trial that showed supplementation of
essential fatty acids significantly lowered the risk of
death, and that use of this supplement was safe.
Interestingly, this trial used a supplement with a ratio
of DHA to EPA of approximately 2:1. This is
important to note, as most fish oil products contain
more EPA than DHA. The exact reasons for such
dramatic benefits with respect to heart disease
remains unknown, but may be related in part to the
ability of fish oil to reduce inflammation, a process
intricately involved in the progression of
atherosclerosis. Some researchers believe that the
body’s inflammatory response to certain factors,
along with a fatty diet, can increase the amount of
plaque in the arteries, leading to atherosclerosis.
Studies indicate that EPA and DHA can act as
precursors for the anti-inflammatory prostaglandins
E1 and E3, and decrease the formation of pro-inflammatory
prostaglandin E2 and thromboxane A2.
Scientists have also suggested that omega-3 fatty
acids can have a direct cardiac effect on
arrhythmogenesis. Omega- 3 fatty acids may be able
to modify sodium channels by binding to the channel
proteins. This could then prevent ischemia-induced
ventricular fibrillation and sudden cardiac death.
Additionally, Opti-DHA is enteric-coated,
significantly reducing the fishy taste sometimes
associated with marine lipid supplements.
Adults take 2 softgel capsules daily with meals or as
directed by physician.
| Supplement Facts (Opti-DHA Enteric-Coated, Douglas Labs)|
Container Size 60 SoftGels
| Serving Size 2 Gels|
| ||Amount Per 2 Gels||Content||%DV|
| ||Total Fat||1 g||2 %|
| ||Vitamin E (as d-alpha tocopherol)||3 IU||10%|
| ||Marine Lipid Concentrate||1000 mg||*|
| || Yielding Docosahexaenoic Acid (DHA)||450 mg||*|
| || Yielding Eicosapentaenoic Acid (EPA)||150 mg||*|
| ||% Daily Values (DV) are based on a 2,000 calorie diet.|
* Daily Value (DV) not established.
The statements provided are for information use only and is not intended to substitute advice from your physician or health care provider. Always follow the manufacturer's recommended dosage or suggested use. If you have any special medical condition including pregnancy or nursing, consult your physician.